Market revenue in 2023 | USD 3,499.3 million |
Market revenue in 2030 | USD 0.0 million |
Growth rate | -100% (CAGR from 2023 to 2030) |
Largest segment | Gene therapy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Gene Therapy, Cell Therapy, Tissue Engineered, Others (Combined ATMPs, for example biodegradable matric or scaffold) |
Key market players worldwide | Bluebird bio Inc, Novartis AG ADR, UniQure NV, Gilead Sciences Inc, JCR Pharmaceuticals Co Ltd, Vericel Corp, Organogenesis Holdings Inc Class A, Spark Therapeutics, Celgene, Kolon Industries, Medipost, Pharmicell |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to advanced therapy medicinal products market will help companies and investors design strategic landscapes.
Gene therapy was the largest segment with a revenue share of 52% in 2023. Horizon Databook has segmented the North America advanced therapy medicinal products market based on gene therapy, cell therapy, tissue engineered, others (combined atmps, for example biodegradable matric or scaffold) covering the revenue growth of each sub-segment from 2018 to 2030.
Factors such as a strong regulatory framework for promoting development of cellular therapy, high cost of therapies in the U.S., and presence of a substantial number of companies in the region have resulted in North America’s leading revenue share.
The strong regulatory framework is a key factor in shaping the U.S. market. FDA continues to make attempts to improve guidelines regarding promotion, development, approval, and legal practice surrounding cellular therapies.
FDA is working to support innovators in bringing new and effective therapies to patients as quickly as possible. Companies are working in collaboration with regulatory agencies to fit into the regulatory model in advanced therapies.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America advanced therapy medicinal products market , including forecasts for subscribers. This continent databook contains high-level insights into North America advanced therapy medicinal products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account